Adicet Bio, Inc. — Director's Dealing 2021

Oct 14, 2021

SEC Form 3/A — Form 3/A

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-10-12

Reporting Person: Aftab Blake (Chief Scientific Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$15.93	2031-04-29	Common Stock (50000)		Direct

Footnotes

F1: 25% of the shares shall vest on the first anniversary of April 5, 2021 (the "Vesting Commencement Date") and as to the remaining 75% of such shares in thirty-six (36) equal monthly installments following the first anniversary of the Vesting Commencement Date; provided that the option holder remains continuously engaged by the Company on each such date.